Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Sees Significant Growth in Short Interest

Posted by Trent Williams on Apr 28th, 2024

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,200 shares, a growth of 46.7% from the March 31st total of 1,500 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average daily volume of 23,800 shares, the short-interest ratio is presently 0.1 days.

Bellevue Life Sciences Acquisition Trading Up 0.2 %

Shares of NASDAQ BLAC traded up $0.03 during mid-day trading on Friday, reaching $10.71. 374,100 shares of the company were exchanged, compared to its average volume of 27,023. The firm has a 50-day moving average of $10.66 and a 200 day moving average of $10.55. Bellevue Life Sciences Acquisition has a 1 year low of $10.11 and a 1 year high of $11.16.

Institutional Trading of Bellevue Life Sciences Acquisition

Several hedge funds have recently modified their holdings of the company. Condor Capital Management bought a new position in shares of Bellevue Life Sciences Acquisition during the 4th quarter worth approximately $121,000. Cowen AND Company LLC acquired a new stake in shares of Bellevue Life Sciences Acquisition in the 4th quarter worth $165,000. Wealthspring Capital LLC purchased a new position in Bellevue Life Sciences Acquisition during the 3rd quarter worth $209,000. Robinson Capital Management LLC acquired a new position in Bellevue Life Sciences Acquisition during the 3rd quarter valued at about $438,000. Finally, Deltec Asset Management LLC purchased a new stake in Bellevue Life Sciences Acquisition in the third quarter valued at about $1,105,000. 55.30% of the stock is owned by hedge funds and other institutional investors.

Bellevue Life Sciences Acquisition Company Profile

(Get Free Report)

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp.